Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats

Yitong Liu(China Pharmaceutical University), Haiping Hao, Hong‐Guang Xie, Li Sze Lai, Qiong Wang, Changxiao Liu, Guangji Wang
Drug Metabolism and Disposition
July 16, 2010
10.1124/dmd.110.033936
Cited by 337

Abstract

Related Papers

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
Weijia Kong, Jing Wei, Parveen Abidi et al.|Nature Medicine|2004|1.4k
The anti-inflammatory potential of berberine in vitro and in vivo
Chi-Li Kuo, Chin‐Wen Chi, Tsung‐Yun Liu|Cancer Letters|2003|683
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang, Jing Wei, Rong Xue et al.|Metabolism|2009|432
Berberine sulfate: antimicrobial activity, bioassay, and mode of action
AR Amin, T. V. Subbaiah, Kobra Abbasi|Canadian Journal of Microbiology|1969|297
Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry
Feng Zuo, Norio Nakamura, Teruaki Akao et al.|Drug Metabolism and Disposition|2006|280